NEW
Stock Screener with Intrinsic Value
Alnylam Pharmaceuticals, Inc. (ALNY)
Last Price$238.0(1.1%)
Market Cap$30.1B
21.5%
Peers median - 14.5%
0.8%
Peers median - 12.4%
4,023.7%
Peers median - 7.9%
(19.0%)
Peers median - (16.7%)
Competing with ALNY
Overview
Ratings
Intrinsic Value
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Crunching data... Almost there!
Compare ALNY Valuation Multiples with Peers
Crunching data... Almost there!
Compare ALNY Valuation Multiples Dynamics with Peers
Crunching data... Almost there!
FAQ
1. How does Alnylam Pharmaceuticals, Inc. (ALNY) revenue growth compare to peers and the industry?
Alnylam Pharmaceuticals, Inc. (ALNY) revenue growth is 21.5%, compared to the peers' median of 14.5%.
2. How does Alnylam Pharmaceuticals, Inc. (ALNY) Free Cash Flow (FCF) margin compare to peers and the industry?
Alnylam Pharmaceuticals, Inc. (ALNY) FCF margin is 0.8%, compared to the peers' median of 12.4%.
3. How does Alnylam Pharmaceuticals, Inc. (ALNY) Total Debt to Equity ratio compare to peers and the industry?
Alnylam Pharmaceuticals, Inc. (ALNY) Total Debt to Equity ratio is 4,023.7%, compared to the peers' median of 7.9%.
4. How does Alnylam Pharmaceuticals, Inc. (ALNY) ROIC (Return on Invested Capital) compare to peers and the industry?
Alnylam Pharmaceuticals, Inc. (ALNY) ROIC is (19.0%), compared to the peers' median of (16.7%).